nafoxidine has been researched along with Prostatic Hyperplasia in 1 studies
Nafoxidine: An estrogen antagonist that has been used in the treatment of breast cancer.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trachtenberg, J | 1 |
1 other study available for nafoxidine and Prostatic Hyperplasia
| Article | Year |
|---|---|
Androgen receptor content of nafoxidine treated experimentally induced canine prostatic hyperplasia.
Topics: Androstane-3,17-diol; Animals; Dogs; Estradiol; Male; Nafoxidine; Prostatic Hyperplasia; Pyrrolidine | 1985 |